Literature DB >> 22969880

Steady and fluctuant methods of inhibition of acetylcholinesterase differentially regulate neurotrophic factors in the hippocampus of juvenile mice.

Chong Li1, Tian Wang, Na Jiang, Pengfei Yu, Yuan DU, Rutong Ren, Fenghua Fu.   

Abstract

The present study was designed to evaluate the effects of steady and fluctuant inhibition of acetylcholinesterase (AChE) activity on neurotrophic factors in the hippocampus of juvenile mice. Steady inhibition of AChE activity was induced by an intramuscular injection of huperizine A (HupA) sustained-release microspheres. Fluctuant inhibition of AChE activity was induced by an intragastric administration of HupA tablets. Six days after cessation of steady AChE inhibition, there was a significant increase in the levels of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF). In contrast, fluctuant AChE inhibition had no effect on BDNF and NGF levels. Additionally, neither steady nor fluctuant inhibition of AChE activity altered the choline acetyltransferase activity or spatial learning in juvenile mice. These findings indicate that steady and fluctuant methods of inhibition of AChE have different effects on the levels of BDNF and NGF in the hippocampus. In addition, the effects of AChE inhibitors may not improve learning in normal juvenile animals.

Entities:  

Year:  2011        PMID: 22969880      PMCID: PMC3438584          DOI: 10.3892/etm.2011.391

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  23 in total

Review 1.  Choline acetyltransferase: the structure, distribution and pathologic changes in the central nervous system.

Authors:  Y Oda
Journal:  Pathol Int       Date:  1999-11       Impact factor: 2.534

Review 2.  Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.

Authors:  Rui Wang; Han Yan; Xi-can Tang
Journal:  Acta Pharmacol Sin       Date:  2006-01       Impact factor: 6.150

Review 3.  Developmental aspects of the cholinergic system.

Authors:  Yael Abreu-Villaça; Cláudio C Filgueiras; Alex C Manhães
Journal:  Behav Brain Res       Date:  2010-01-06       Impact factor: 3.332

Review 4.  Alzheimer's disease: a disorder of cortical cholinergic innervation.

Authors:  J T Coyle; D L Price; M R DeLong
Journal:  Science       Date:  1983-03-11       Impact factor: 47.728

5.  Prolonged effects of poly(lactic-co-glycolic acid) microsphere-containing huperzine A on mouse memory dysfunction induced by scopolamine.

Authors:  Chaoyun Wang; Taiping Zhang; Hongmei Ma; Juntian Liu; Fenghua Fu; Ke Liu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2007-03       Impact factor: 4.080

6.  Effects of huperzine A on secretion of nerve growth factor in cultured rat cortical astrocytes and neurite outgrowth in rat PC12 cells.

Authors:  Li-li Tang; Rui Wang; Xi-can Tang
Journal:  Acta Pharmacol Sin       Date:  2005-06       Impact factor: 6.150

7.  Septal cholinergic afferents regulate expression of brain-derived neurotrophic factor and beta-nerve growth factor mRNA in rat hippocampus.

Authors:  N Lindefors; P Ernfors; T Falkenberg; H Persson
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

8.  Pharmacokinetics of Huperzine A after transdermal and oral administration in beagle dogs.

Authors:  J C Ye; S Zeng; G L Zheng; G S Chen
Journal:  Int J Pharm       Date:  2008-01-12       Impact factor: 5.875

9.  Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus.

Authors:  M da Penha Berzaghi; J Cooper; E Castrén; F Zafra; M Sofroniew; H Thoenen; D Lindholm
Journal:  J Neurosci       Date:  1993-09       Impact factor: 6.167

10.  Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons.

Authors:  C Crowley; S D Spencer; M C Nishimura; K S Chen; S Pitts-Meek; M P Armanini; L H Ling; S B McMahon; D L Shelton; A D Levinson
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

View more
  1 in total

1.  Structural and functional brain alterations in patients with myasthenia gravis.

Authors:  Benita Klaus; Patrick Müller; Nora van Wickeren; Milos Dordevic; Marlen Schmicker; Yael Zdunczyk; Tanja Brigadski; Volkmar Leßmann; Stefan Vielhaber; Stefanie Schreiber; Notger G Müller
Journal:  Brain Commun       Date:  2022-02-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.